Dendrimers in Cancer Therapeutics and Diagnosis

被引:33
|
作者
Guo, Rui [1 ,2 ]
Shi, Xiangyang [1 ,2 ,3 ]
机构
[1] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China
[2] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China
[3] Univ Madeira, CQM Ctr Quim Madeira, P-9000390 Funchal, Portugal
基金
中国国家自然科学基金;
关键词
Dendrimer; anticancer drug delivery; cancer diagnosis; IRON-OXIDE NANOPARTICLES; MRI CONTRAST AGENTS; TERMINATED POLY(AMIDOAMINE) DENDRIMER; ENTRAPPED GOLD NANOPARTICLES; TARGETED DRUG-DELIVERY; PAMAM-DENDRIMER; DOXORUBICIN DELIVERY; ANTICANCER ACTIVITY; MOLECULAR-WEIGHT; CONJUGATED PAMAM;
D O I
10.2174/138920012802850010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendrimers represent a class of monodispersed synthetic macromolecules with a well defined three-dimensional structure of nanometer dimension in which a series of layered branches regularly extend from a central core molecule. Due to their precise nanoscale sizes, well-defined branched structures, and various surface modifications, dendrimers have been extensively investigated in a wide range of applications in the biomedical field, particularly in the therapeutics and diagnosis of cancer. This article gives an overview of the recent advances of dendrimers and dendrimer-based hybrid nanoparticles for cancer therapeutics and diagnosis applications.
引用
收藏
页码:1097 / 1109
页数:13
相关论文
共 50 条
  • [21] Cancer Invasion and Metastasis: Discovering New Targets For Diagnosis and Therapeutics
    Alessandro, Riccardo
    Fontana, Simona
    De Leo, Giacomo
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (03) : 152 - 161
  • [22] Nanozymes: A comprehensive review on emerging applications in cancer diagnosis and therapeutics
    Deshwal, Akanksha
    Saxena, Kirti
    Sharma, Garima
    Rajesh
    Sheikh, Faheem A.
    Seth, Chandra Shekhar
    Tripathi, Ravi Mani
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 256
  • [23] Targeting alternatively spliced sequence features for cancer diagnosis and therapeutics
    Levan Atanelov
    Qiang Xu
    Ramin Rad
    Christopher Lee
    Journal of Gastroenterology, 2005, 40 : 14 - 20
  • [24] Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets
    Boyce, EA
    Kohn, EC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 : 266 - 273
  • [25] Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives
    Rodriguez Villanueva, Javier
    Guzman Navarro, Manuel
    Rodriguez Villanueva, Laura
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (01) : 359 - 366
  • [26] Preface: Polymer science and polymer therapeutics: Macromolecules, dendrimers and nanomedicine
    Micha-Screttas, Maria
    Ringsdorf, Helmut
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (14) : 1161 - 1164
  • [27] Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives
    Cheng, Yiyun
    Zhao, Libo
    Li, Yiwen
    Xu, Tongwen
    CHEMICAL SOCIETY REVIEWS, 2011, 40 (05) : 2673 - 2703
  • [28] ROS-Responsive Ferrocenyl Amphiphilic PAMAM Dendrimers for On-Demand Delivery of siRNA Therapeutics to Cancer Cells
    Chen, Peng
    Wang, Zhihui
    Wang, Xinmo
    Gong, Junni
    Sheng, Ju
    Pan, Yufei
    Zhu, Dandan
    Liu, Xiaoxuan
    PHARMACEUTICS, 2024, 16 (07)
  • [29] Overview on in vitro and in vivo investigations of nanocomposite based cancer diagnosis and therapeutics
    Subramanian, A. P.
    Jaganathan, S. K.
    Supriyanto, Eko
    RSC ADVANCES, 2015, 5 (89) : 72638 - 72652
  • [30] CANCER AND CANCER THERAPEUTICS
    Mellerio, Jemima
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 24 - 24